Siegfried Schlunk and Brett Byram. “Expanding gCNR into a Clinically Relevant Measure of Lesion Detectability by Considering Size and Spatial Resolution.” Proceedings of SPIE Medical Imaging 2024: Ultrasonic Imaging and Tomography, vol. 12932, 1293205, 2024, San Diego, California,
Early image quality metrics were often developed with the goal of aligning with clinicians’ subjective opinions on what constitutes better images. As imaging techniques advanced, especially with the introduction of adaptive beamformers and other post-processing methods, these older metrics often failed to remain accurate. This disconnect allowed some beamformers to manipulate these metrics without actually improving clinical image quality.
In this work, a metric known as the Signal-to-Noise Ratio (SNR) for lesion detectability, originally proposed by Smith et al., is examined and improved. The new version, called generalized SNR (gSNR), incorporates the generalized Contrast-to-Noise Ratio (gCNR) to provide more reliable assessments that resist manipulation. Unlike gCNR, the original SNR includes lesion size and spatial resolution in its calculations, which enhances its robustness.
The paper analytically demonstrates that for Rayleigh-distributed data, gCNR can be expressed in terms of another metric, Cψ, proposed by Smith et al. This allows gCNR to substitute for SNR while also considering more accurate methods for estimating resolution cell size. Consequently, the gSNR provides a more reliable measure of lesion detectability that better aligns with clinical evaluations of image quality.